Zokinvy, illustration of capsule form (not a photo of the actual pack)

Illustrative image.

Zokinvy

Lonafarnib

Prescription required

$40895.00

50mg · 30 capsules

BrandBranded medicine· By Sentynl Therapeutics

Strength

Choose a pack

  • Selected pack

Packs in this delivery

1

Test mode: no payment is taken. View cart

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

50mg

75MG

About Zokinvy

Overview

Zokinvy (lonafarnib) is a prescription capsule for patients aged 12 months and older with a body surface area of at least 0.39 m². It is used to reduce the risk of death in Hutchinson-Gilford Progeria Syndrome and to treat certain processing-deficient progeroid laminopathies involving a heterozygous LMNA mutation with progerin-like protein accumulation, or homozygous or compound heterozygous ZMPSTE24 mutations. It is not indicated for other progeroid syndromes or processing-proficient progeroid laminopathies. It works by blocking an enzyme called farnesyltransferase, helping prevent progerin and progerin-like proteins from building up in the inner membrane surrounding the cell’s nucleus.

What it treats

For patients aged 12 months and older with a body surface area of at least 0.39 m²: - Hutchinson-Gilford Progeria Syndrome (HGPS), to reduce the risk of death. - Processing-deficient progeroid laminopathies with either a heterozygous LMNA mutation causing progerin-like protein accumulation, or homozygous or compound heterozygous ZMPSTE24 mutations. Not indicated for other progeroid syndromes or processing-proficient progeroid laminopathies.

Safety information

Side effects

Common side effects include vomiting, diarrhea, nausea, decreased appetite, tiredness, abdominal pain, muscle and joint pain, weight loss, headache, cough, infections, upper respiratory tract infections, and high blood pressure. Common laboratory changes include electrolyte imbalances, reduced blood bicarbonate, reduced blood cell production, and increased liver enzymes. Zokinvy can prolong the QTc interval, a change in the heart’s electrical activity. It should be avoided in people with a slow heartbeat that causes symptoms, low potassium or magnesium levels, or those taking other medicines that prolong the QTc interval. Other drug interactions can increase side effects or reduce treatment effectiveness, so your doctor should review your medicines before and during treatment. Contact your doctor if you notice any new vision changes. Low-light vision decline occurred in monkeys, and kidney toxicity occurred in rats. Regular eye examinations and kidney function checks are recommended. Your doctor should also monitor electrolytes, blood cell counts, and liver enzymes. Zokinvy can harm an unborn baby. Contact your doctor if you become pregnant or think you may be pregnant, and use effective contraception if you could become pregnant. Animal studies also found impaired fertility and damage to male reproductive organs; discuss potential fertility risks with your doctor.

When to call your doctor

- Seek medical attention right away for any new changes in your vision.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not take Zokinvy with strong CYP3A inhibitors, strong or moderate CYP3A inducers, midazolam, lovastatin, simvastatin or atorvastatin. Your prescriber should review your other medicines before and during treatment because interactions may reduce effectiveness or increase adverse reactions. Zokinvy can prolong the QTc interval, a measure of the heart’s electrical activity. Avoid use if you have a slow heartbeat that causes symptoms, low blood potassium or magnesium, or take other medicines known to prolong the QTc interval. Treatment requires monitoring of electrolytes, blood cell counts, liver enzymes and kidney function. Regular eye examinations are also needed, with an examination if any new vision changes occur. Kidney damage and reduced low-light vision were seen in animal studies. Zokinvy can harm an unborn baby. Females who could become pregnant should use effective contraception. Animal studies also found impaired fertility and harm to male reproductive organs; discuss these risks with your prescriber.

Interactions

Avoid taking Zokinvy with medicines that prolong the QTc interval, a change in the heart’s electrical activity. Ask your doctor to check your other medicines for interactions. The label notes that other clinically significant interactions are detailed in the full prescribing information.

Using Zokinvy

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label ZOKINVY (LONAFARNIB) CAPSULE [SENTYNL THERAPEUTICS, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines